| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
40 |
| Employees |
100 |
| Revenues (TTM) (Millions $) |
212 |
| Net Income (TTM) (Millions $) |
-143 |
| Cash Flow (TTM) (Millions $) |
-78 |
| Capital Exp. (TTM) (Millions $) |
26 |
Business Description
Lucira Health Inc.
is a medical technology company based in the United States that focuses on developing and commercializing innovative technologies for healthcare providers and consumers.
The company specializes in the areas of molecular diagnostics, mobile health, and medical devices.
The company is best known for its Lucira Check-It COVID-19 At-Home Test Kit, a single-use, molecular test designed to detect the presence of the virus that causes COVID-19.The Lucira Check-It COVID-19 At-Home Test Kit is a portable, quick, and easy-to-use at-home test that helps individuals self-diagnose COVID-19 within 30 minutes.
The test is authorized for emergency use in the United States by the Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) and is the first COVID-19 test that is fully self-contained, enabling users to complete the entire testing process at home without needing to send their samples to a laboratory.Lucira Health Inc.
was founded in 2013 and is headquartered in Emeryville, California.
The company has partnerships with several healthcare and biotech companies, including Abbott and JSR Life Sciences, to optimize its diagnostic technology and expand its market reach.
In addition to its COVID-19 test, the company is also developing other diagnostic products that focus on infectious diseases, cancer, and women's health.
Company Address: 1412 62nd Street Emeryville 94608 CA
Company Phone Number: 350-8071 Stock Exchange / Ticker: NASDAQ LHDX
|
%